Jie Ming

3.0k total citations
114 papers, 2.0k citations indexed

About

Jie Ming is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jie Ming has authored 114 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 46 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Jie Ming's work include Thyroid Cancer Diagnosis and Treatment (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers) and Cancer-related molecular mechanisms research (9 papers). Jie Ming is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers) and Cancer-related molecular mechanisms research (9 papers). Jie Ming collaborates with scholars based in China, United States and United Kingdom. Jie Ming's co-authors include Shaoyong Xu, Tao Huang, Qiuhe Ji, Qiuhe Ji, Bo Tian, Ying Xing, Pei Zhang, Chunping Liu, Yi Wan and Lan Shi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Neuron.

In The Last Decade

Jie Ming

109 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Ming China 26 648 519 297 286 266 114 2.0k
Motoaki Saito Japan 28 610 0.9× 329 0.6× 213 0.7× 460 1.6× 448 1.7× 192 2.6k
Anastasios Kalofoutis Greece 26 459 0.7× 462 0.9× 270 0.9× 365 1.3× 297 1.1× 58 2.3k
Ze Yang China 25 831 1.3× 294 0.6× 285 1.0× 575 2.0× 223 0.8× 144 2.2k
Xiaodong Fu China 30 818 1.3× 386 0.7× 112 0.4× 212 0.7× 150 0.6× 92 2.2k
Seul‐Ki Jeong South Korea 28 494 0.8× 241 0.5× 394 1.3× 300 1.0× 313 1.2× 116 2.3k
Yoshihiko Suzuki Japan 26 1.1k 1.6× 336 0.6× 300 1.0× 369 1.3× 443 1.7× 98 2.4k
Liqun Wang China 29 982 1.5× 152 0.3× 248 0.8× 211 0.7× 368 1.4× 99 2.6k
Krzysztof Łabuzek Poland 23 583 0.9× 317 0.6× 260 0.9× 283 1.0× 327 1.2× 70 1.7k
Richard Imrich Slovakia 24 418 0.6× 320 0.6× 271 0.9× 582 2.0× 165 0.6× 112 2.1k

Countries citing papers authored by Jie Ming

Since Specialization
Citations

This map shows the geographic impact of Jie Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ming more than expected).

Fields of papers citing papers by Jie Ming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ming. The network helps show where Jie Ming may publish in the future.

Co-authorship network of co-authors of Jie Ming

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ming. A scholar is included among the top collaborators of Jie Ming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ming. Jie Ming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Qingyi, Ximeng Zhang, Rong Wang, et al.. (2025). Manganese-Loaded pH-Responsive DNA Hydrogels Enable Tg-Guided Thyroid Tumor Targeted Magnetic Resonance Imaging. ACS Applied Materials & Interfaces. 17(9). 13403–13414. 3 indexed citations
2.
Ming, Jie, Fang Cheng, Meng Zhang, et al.. (2025). Long non-coding RNA H19 promotes cervical cancer development via targeting the microRNA-140/ALDH1A1 axis. European journal of medical research. 30(1). 95–95. 1 indexed citations
3.
Yang, Ting-Lin, Jun Zhou, Ming Xu, et al.. (2024). A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER− cells via endoplasmic reticulum stress-induced apoptosis. Cell Death and Disease. 15(2). 147–147. 1 indexed citations
4.
Wang, Rong, et al.. (2023). Photothermal therapy of copper incorporated nanomaterials for biomedicine. Biomaterials Research. 27(1). 121–121. 19 indexed citations
6.
Cai, Hongwei, Pei Zhang, Tongxia Li, et al.. (2023). Amygdalo‐nigral circuit mediates stress‐induced vulnerability to the parkinsonian toxin MPTP. CNS Neuroscience & Therapeutics. 29(7). 1940–1952. 4 indexed citations
7.
Hu, Jin, Xia Xu, Shuntao Wang, et al.. (2022). Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery. Frontiers in Oncology. 12. 896942–896942. 4 indexed citations
8.
Huang, Tao, et al.. (2021). Male Adenoid Cystic Carcinoma of the Breast. Journal of Medical Cases. 12(12). 503–510. 2 indexed citations
10.
Ming, Jie, Shane J. F. Cronin, & Josef Penninger. (2020). Targeting the RANKL/RANK/OPG Axis for Cancer Therapy. Frontiers in Oncology. 10. 1283–1283. 48 indexed citations
11.
Zhou, Jun, Jie Tan, Jie Ming, et al.. (2020). Management of Very Elderly Patients With Papillary Thyroid Cancer: Analysis of Outcomes for Surgery Versus Nonsurgery. Journal of Surgical Research. 256. 512–519. 6 indexed citations
12.
Woo, Yu Cho, Bin Gao, Chi‐Ho Lee, et al.. (2019). Three‐component non‐invasive risk score for undiagnosed diabetes in Chinese people: Development, validation and longitudinal evaluation. Journal of Diabetes Investigation. 11(2). 341–348. 10 indexed citations
13.
Ming, Jie, Shaoyong Xu, Yangwei Wang, et al.. (2018). Diabetes prevalence and its comorbidities in people aged 50 years and above in Xi'an: a community-based survey. 10(8). 531–536. 1 indexed citations
14.
Sun, Fei, Bin Gao, Li Wang, et al.. (2018). Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population. Diabetes Therapy. 9(4). 1457–1468. 6 indexed citations
15.
Wei, Holly, et al.. (2018). A mixed method analysis of patients' complaints: Underpinnings of theory-guided strategies to improve quality of care. International Journal of Nursing Sciences. 5(4). 377–382. 19 indexed citations
16.
Xu, Shaoyong, et al.. (2017). Epidemic characteristics of obesity in China under various diagnostic criteria. 9(4). 221–225. 3 indexed citations
17.
Ming, Jie, Zeming Liu, Wen Zeng, et al.. (2015). Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.. PubMed. 8(11). 15155–62. 20 indexed citations
18.
Guo, Hui, Wei Chen, Jie Ming, et al.. (2015). Association between polymorphisms in cdc27 and breast cancer in a Chinese population. Tumor Biology. 36(7). 5299–5304. 6 indexed citations
19.
Xu, Shaoyong, Jie Ming, Jing Cai, et al.. (2015). Insulin resistance is not independently associated with chronic kidney disease in Chinese population: A population-based cross-sectional study. Clinica Chimica Acta. 448. 232–237. 8 indexed citations
20.
Xu, Shaoyong, Jie Ming, Ying Xing, et al.. (2013). Regional differences in diabetes prevalence and awareness between coastal and interior provinces in China: a population-based cross-sectional study. BMC Public Health. 13(1). 299–299. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026